secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001213900-23-037345
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius raises ~$15M via registered direct offering of 12.5M shares and warrants
-------------------------------------------------------------------------------

- Issued 12.5M shares and warrants to purchase 12.5M shares at $1.20/unit in registered direct offering.
- Gross proceeds ~$15M; net proceeds for general corporate purposes, including clinical development.
- Warrants have exercise price $1.50, exercisable six months after issuance, expire in five years.
- H.C. Wainwright acted as placement agent; cash fee ~$1.05M plus expenses and placement agent warrants.
- Offering closed May 8, 2023; 60-day lock-up on further equity issuance and one-year restriction on floating-price securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390023037345/0001213900-23-037345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390023037345/ea178024-8k_citiuspharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-037345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer